Stockscreener 앱 받기
1.61
8.78%
0.13
시간 외 거래:
1.61
전일 마감가:
$1.48
열려 있는:
$1.47
하루 거래량:
2.98M
Relative Volume:
2.88
시가총액:
$456.71M
수익:
-
순이익/손실:
$-125.04M
주가수익비율:
-1.9634
EPS:
-0.82
순현금흐름:
$-122.99M
1주 성능:
+2.55%
1개월 성능:
+7.33%
6개월 성능:
+13.38%
1년 성능:
-46.15%
1일 변동 폭
$1.47
$1.61
1주일 범위
$1.3301
$1.66
52주 변동 폭
$1.01
$3.305
Erasca Inc Stock (ERAS) Company Profile
명칭
Erasca Inc
전화
(858) 465-6511
주소
3115 MERRYFIELD ROW, SAN DIEGO
ERAS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ERAS
Erasca Inc
|
1.61 | 419.83M | 0 | -125.04M | -122.99M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Erasca Inc Stock (ERAS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2025-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-26 | 개시 | Raymond James | Outperform |
| 2024-11-18 | 개시 | Jefferies | Buy |
| 2024-03-11 | 개시 | CapitalOne | Overweight |
| 2024-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-10-11 | 개시 | H.C. Wainwright | Buy |
| 2023-03-30 | 개시 | Mizuho | Buy |
| 2023-02-24 | 개시 | Goldman | Buy |
| 2023-02-03 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Erasca Inc 주식(ERAS)의 최신 뉴스
Why Erasca Inc. is moving today2025 Market Overview & Weekly High Return Opportunities - Newser
Is Erasca Inc. stock ready for a breakoutMarket Sentiment Review & Daily Momentum Trading Reports - Newser
Regression analysis insights on Erasca Inc. performanceWeekly Trade Analysis & Risk Controlled Daily Trade Plans - Newser
Leading vs lagging indicators on Erasca Inc. performanceStock Surge & Safe Entry Momentum Tips - Newser
What’s next for Erasca Inc. stock priceTreasury Yields & Daily Profit Focused Screening - Newser
Applying Elliott Wave Theory to Erasca Inc.Portfolio Gains Report & Daily Growth Stock Investment Tips - Newser
Multi asset correlation models including Erasca Inc.July 2025 Trends & Community Consensus Picks - Newser
Is this a good reentry point in Erasca Inc.2025 Top Gainers & High Accuracy Buy Signal Tips - Newser
How to recover losses in Erasca Inc. stockPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - Newser
Can Erasca Inc. keep up with sector leaders2025 Buyback Activity & Long-Term Growth Portfolio Plans - خودرو بانک
What technical models suggest about Erasca Inc.’s comebackJuly 2025 Sector Moves & Stepwise Trade Execution Plans - Newser
Using data tools to time your Erasca Inc. exit2025 AllTime Highs & Intraday High Probability Alerts - Newser
Will Erasca Inc. outperform during market ralliesJuly 2025 Volume & Low Volatility Stock Recommendations - خودرو بانک
Nuveen LLC Takes Position in Erasca, Inc. $ERAS - Defense World
Does Erasca Inc. show high probability of reboundQuarterly Earnings Report & Fast Exit and Entry Trade Guides - Newser
How moving averages guide Erasca Inc. tradingJuly 2025 Reactions & Daily Profit Focused Stock Screening - Newser
Relative strength of Erasca Inc. in sector analysis2025 Price Targets & Free Verified High Yield Trade Plans - Newser
Published on: 2025-09-04 00:19:00 - Newser
Erasca Shares Fall After BofA Securities Downgrade - MarketScreener
Bank of America Downgrades Erasca, Candle, and Xencor Due to Lack of Near-Term Catalysts - AInvest
Erasca, Candle, Xencor drop as BofA downgrades on lack of near-term catalysts - Seeking Alpha
This Accenture Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
Will Erasca Inc. be affected by tariffsStock Surge & Stock Market Timing Techniques - خودرو بانک
Is Erasca Inc. stock heavily shortedWeekly Trade Report & AI Based Buy and Sell Signals - خودرو بانک
BofA Securities Downgrades Erasca to Underperform - MarketScreener
BofA Securities downgrades Erasca stock to Underperform on competitive concerns - Investing.com
Applying chart zones and confluence areas to Erasca Inc.Earnings Recap Report & Daily Market Momentum Tracking - Newser
Tools to monitor Erasca Inc. recovery probabilityFed Meeting & Comprehensive Market Scan Reports - Newser
What MACD signals say about Erasca Inc.Market Risk Summary & Technical Pattern Based Signals - Newser
Trend analysis for Erasca Inc. this weekEarnings Overview Summary & Weekly High Return Opportunities - Newser
Using economic indicators to assess Erasca Inc. potentialEarnings Growth Summary & Verified Stock Trade Ideas - Newser
Will Erasca Inc. outperform the marketTake Profit & Weekly High Conviction Trade Ideas - Newser
What are Erasca Inc.’s growth leversTrade Volume Report & Free Community Consensus Stock Picks - خودرو بانک
Advanced analytics toolkit walkthrough for Erasca Inc.July 2025 Review & Reliable Momentum Entry Alerts - Newser
How liquid is Erasca Inc. stock2025 Growth vs Value & Fast Moving Stock Watchlists - خودرو بانک
Will Erasca Inc. stock recover after earningsWeekly Market Report & Consistent Profit Focused Trading Strategies - خودرو بانک
Erasca, Inc. shares rise 4.78% intraday after announcing participation in Morgan Stanley 23rd Annual Global Healthcare Conference. - AInvest
Erasca to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference - The Manila Times
Precision Oncology Company Erasca to Share RAS/MAPK Cancer Therapy Updates at Morgan Stanley Conference - Stock Titan
Earnings visualization tools for Erasca Inc.Quarterly Portfolio Summary & High Accuracy Buy Signal Tips - Newser
Published on: 2025-09-02 05:49:34 - Newser
Erasca Inc (ERAS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):